News August 1, 2023 Funding announcement: Dr. Lawrence Vernetti has received an SBIR grant in collaboration with Numa Biosciences (formerly Nortis, Inc.) beginning August 1, 2023 for “A liver-on-chip platform to evaluate panels of clinically relevant gene variants for screening of xenobiotic compounds”. August 1, 2023 Dr. Lawrence Vernetti will present a webinar to AnaBios entitled: “ Use of Human Liver Cells in Microphysiology Systems” to take place August 31, 2023 at 11 am EDT. June 28, 2023 BioSystics, Inc., a database and analytics company, announced that it has merged with Nortis, a microphysiology systems platform company, to form Numa Biosciences, Inc., a precision medicine platform company. June 13, 2023 Dr. D. Lansing Taylor and Dr. Mark Schurdak will participate in the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Workshop on September 28 – 29, 2023 at the NIH Campus in Bethesda, MD. « Previous 1 2 3 4 5 6 … 23 Next »